I agree that this site is using cookies. You can find further informations here.
X
Ahlstrand, Erik
40  results:
Search for persons X
?
1

Correction: Treatment-free remission after a second TKI dis..:

Flygt, Hjalmar ; Söderlund, Stina ; Richter, Johan...
Leukemia.  38 (2024)  4 - p. 925-925 , 2024
Link: https://doi.org/10.1038/..
 
?
2

Treatment-free remission after a second TKI discontinuation..:

Flygt, Hjalmar ; Söderlund, Stina ; Richter, Johan...
Leukemia.  38 (2024)  4 - p. 781-787 , 2024
Link: https://doi.org/10.1038/..
 
?
3

Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment w..:

Partanen, Anu ; Waage, Anders ; Peceliunas, Valdas...
Cancers.  16 (2024)  5 - p. 1024 , 2024
Link: https://doi.org/10.3390/..
 
?
4

P898: A PROSPECTIVE PHASE 2 STUDY TO ASSESS MINIMAL RESIDUA..:

Silvennoinen, Raija ; Partanen, Anu ; Waage, Anders...
HemaSphere.  7 (2023)  S3 - p. e5534069 , 2023
Link: https://doi.org/10.1097/..
 
?
5

Haematopoietic stem cell transplantation for treatment of r..:

Silfverberg, Thomas ; Zjukovskaja, Christina ; Ljungman, Per...
Journal of Neurology, Neurosurgery & Psychiatry.  95 (2023)  2 - p. 125-133 , 2023
Link: https://doi.org/10.1136/..
 
?
6

P898: A PROSPECTIVE PHASE 2 STUDY TO ASSESS MINIMAL RESIDUA..:

Silvennoinen, Raija ; Partanen, Anu ; Waage, Anders...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430912/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
7

P898: A PROSPECTIVE PHASE 2 STUDY TO ASSESS MINIMAL RESIDUA..:

Raija Silvennoinen ; Anu Partanen ; Anders Waage...
http://journals.lww.com/10.1097/01.HS9.0000970496.55340.69.  , 2023
Link: https://doi.org/10.1097/..
 
?
8

Survival and risk of vascular complications in myelofibrosi..:

Lindgren, Marie ; Andréasson, Björn ; Samuelsson, Jan...
European Journal of Haematology.  109 (2022)  4 - p. 336-342 , 2022
Link: https://doi.org/10.1111/..
 
?
9

RT-PCR cycle threshold value in combination with visual sco..:

Ingberg, Edvin ; Ahlstrand, Erik ; Cajander, Per...
Infectious Diseases.  54 (2022)  6 - p. 431-440 , 2022
Link: https://doi.org/10.1080/..
 
?
10

P-222: A prospective phase 2 study to assess minimal residu..:

Silvennoinen, Raija ; Waage, Anders ; Peceliunas, Valdas...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S157 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Molecular status 36 months after TKI discontinuation in CML..:

Richter, Johan ; Lubking, Anna ; Soderlund, Stina...
10.1038/s41375-021-01173-w.  , 2022
Link: http://hdl.handle.net/10..
 
?
12

RT-PCR cycle threshold value in combination with visual sco..:

Edvin Ingberg (5123633) ; Erik Ahlstrand (572504) ; Per Cajander (10633572)...
https://figshare.com/articles/journal_contribution/RT-PCR_cycle_threshold_value_in_combination_with_visual_scoring_of_chest_computed_tomography_at_hospital_admission_predicts_outcome_in_COVID-19/19121701.  , 2022
Link: https://doi.org/10.6084/..
 
?
13

Visual scoring of chest CT at hospital admission predicts h..:

Ahlstrand, Erik ; Cajander, Sara ; Cajander, Per...
Infectious Diseases.  53 (2021)  8 - p. 622-632 , 2021
Link: https://doi.org/10.1080/..
 
?
14

Molecular status 36 months after TKI discontinuation in CML..:

Richter, Johan ; Lübking, Anna ; Söderlund, Stina...
Leukemia.  35 (2021)  8 - p. 2416-2418 , 2021
Link: https://doi.org/10.1038/..
 
?
15

Molecular status 36 months after TKI discontinuation in CML..:

Richter, Johan ; Lubking, Anna ; Soderlund, Stina...
Leukemia, 0887-6924, 2021, 35, s. 2416-2418.  , 2021
Link: http://urn.kb.se/resolve..
 
1-15